IDEXX Laboratories, Inc. Price Today
IDEXX Laboratories, Inc.
IDXX
Healthcare
$41.84B
💰
Market Cap
60.8
💸
Price to Earnings
$8.3
🎉
EPS
+0
🌳
ESG
Consensus Recommendations
Buy Consensus
Buy |
10 |
Strong Buy |
3 |
Hold |
5 |
Sell |
0 |
Strong Sell |
0 |
IDXX Price Forecast Target
504.1 👉 600.0 +19%
IDXX EPS Forecast
8.3 👉 11.1 +34%
Financials
Profit Margin
23 %
Revenue Growth
9.7 %
Dividend
$ 0
Held Percent
0.9% - Insiders
91.3% - Institutions
7.8% - Public
Major Fund Holders
-
💰 Blackrock Inc. $4.4B
-
💰 Vanguard Group Inc $4.1B
-
💰 State Street Corporation $1.8B
-
💰 Alliancebernstein L.P. $1.7B
-
💰 Fundsmith LLP $1.5B
Stock Ideas
Andreas Halvorsen Portfolio
Andreas Halvorsen is a Norwegian billionaire investor, hedge fund manager, and the founder of Viking Global Investors, a large hedge fund with over $50 billion in assets under management. He is known for his long-term, value-oriented investment appr…
Steven Cohen Portfolio
Steven Cohen, the legendary trader and billionaire founder of Stamford-based SAC Capital, has established himself as a force to be reckoned with in the hedge fund industry. With a staggering net worth of $8 billion and an impressive $14 billion in …
Louis Bacon Portfolio
Louis Bacon is the founder of Moore Capital Management and is one of the famous traders of the past two decades. His personal wealth is more than $1.5 Billion and had more than $15 Billion in AUM. He has an MBA degree from Columbia Business School.
Larry Robbins Portfolio
Larry Robbins is a successful hedge fund manager who founded Glenview Capital in 2001 after working as a trader at Omega Advisors. His portfolio strategy has led to impressive returns, with Glenview Capital returning 301% after fees and expenses bet…📮FAQ
Some Frequently Asked Questions.
The IDEXX Laboratories, Inc. industry is Diagnostics & Research
The IDEXX Laboratories, Inc. sector is Healthcare
The IDEXX Laboratories, Inc. forecasted predicted Price to Earnings PE ratio is 45.4
The IDEXX Laboratories, Inc. Price to Earnings PE ratio is 60.8
The Market Capitalization of IDEXX Laboratories, Inc. is $41.84B
There are total of 82162361 float shares with 91.3% held by Institutions and 0.9% held by insiders
The MIDEXX Laboratories, Inc. forecasted Earnings per Share EPS is $11.1
The IDEXX Laboratories, Inc. Earnings per Share EPS is 8.3
The IDEXX Laboratories, Inc. company has $2004338000 gross profits with 23 profit margins
The IDEXX Laboratories, Inc. Earnings Growth is 0.712% with 0.699% quarterly earnings growth
The IDEXX Laboratories, Inc. Revenue is $3514053888 with 0.097 revenue growth
The price target for IDEXX Laboratories, Inc. stock is $600.0 for the high target and $523.0 for the low target
The consensus analyst recommendations for IDEXX Laboratories, Inc. is Buy, however the decision to buy or sell the stock should be entirely yours, as you are earning your own money and hence responsible on how to allocate and spend them.
The consensus analyst recommendations for IDEXX Laboratories, Inc. is Buy, with the following breakdown:
- Buy: 10
- Strong Buy: 3
- Hold: 5
- Sell: 0
- Strong Sell: 0
The Beta of IDEXX Laboratories, Inc. is 1.2
The dividend of IDEXX Laboratories, Inc. is $0
The dividend yield of IDEXX Laboratories, Inc. is 0%
The biggest institutional and mutual fund holders of IDEXX Laboratories, Inc. stock are
- Blackrock Inc.
- Vanguard Group Inc
- State Street Corporation
- Alliancebernstein L.P.
The IDEXX Laboratories, Inc. ESG Score is 0, with the following breakdown:
- E: 0
- S: 0
- G: 0